1. Home
  2. Documents
  3. Documents

Immunization Documents

Date Range
Measles Rubella Weekly Bulletin (32) - 14 August 2021
Technical bulletins
Polio Weekly Bulletin (32) - 14 August 2021
Technical bulletins
requently-asked-questions-meningococcal-disease-paho-2022-en
Frequently Asked Questions on Meningococcal Disease
Technical and scientific products
Polio Weekly Bulletin (31) - 7 August 2021
Technical bulletins
Measles Rubella Weekly Bulletin (31) - 7 August 2021
Technical bulletins
bacterial pneumonia and meningitis
Surveillance of Bacterial Pneumonia and Meningitis in Children Aged Under 5 Years: Field Guide. Second Edition
Field guides
COVID-19 VACCINE
Interim statement on dose-sparing strategies for COVID-19 vaccines (fractionated vaccine doses)
Technical and scientific products
covid-19 vaccines
Interim statement on COVID-19 vaccine booster doses
Technical and scientific products
COVID-19 vaccines
Interim statement on heterologous priming for COVID-19 vaccines
Technical and scientific products
Polio Weekly Bulletin (30) - 31 July 2021
Technical bulletins
breastfeeding and COVID-19
Breastfeeding and COVID-19 vaccines - Social Media collection
Communication Materials
Measles Rubella Weekly Bulletin (30) - 31 July 2021
Technical bulletins
sireva II 2018
SIREVA II Regional Report, 2018 (in Spanish)
Technical and scientific products
Polio Weekly Bulletin (29) - 24 July 2021
Technical bulletins
Measles Rubella Weekly Bulletin (29) - 24 July 2021
Technical bulletins
Securing Additional COVID-19 vaccines
Technical and scientific products
CD59-INF-7-e-immunization
CD59/INF/7 - Plan of Action on Immunization: Final Report
covid-19 vaccines
Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on reports of Guillain-Barré Syndrome (GBS) following adenovirus vector COVID-19 vaccines
Technical and scientific products
Measles Rubella Weekly Bulletin (28) - 17 July 2021
Technical bulletins
Polio Weekly Bulletin (28) - 17 July 2021
Technical bulletins
sage
WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply
Technical and scientific products